Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit - Stock Options (Details)

v3.19.3
Stockholders' Deficit - Stock Options (Details) - USD ($)
9 Months Ended 12 Months Ended
Jul. 10, 2019
Sep. 30, 2019
Dec. 31, 2018
Equity [Abstract]      
Outstanding (in shares)   2,235,000  
Granted (in shares)   608,550  
Exercised (in shares)   0  
Cancelled (in shares)   0  
Outstanding (in shares)   2,843,550 2,235,000
Exercisable (in shares)   767,125  
Outstanding, Weighted Average Exercise Price (in dollars per share)   $ 1.74  
Granted (in dollars per share) $ 17.50 5.70  
Exercised (in dollars per share)   0  
Cancelled (in dollars per share)   0  
Outstanding, Weighted Average Exercise Price (in dollars per share)   2.59 $ 1.74
Exercisable (in dollars per share)   $ 1.73  
Outstanding, Weighted Average Remaining Life (Year)   8 years 10 months 6 days 9 years 5 months 8 days
Exercisable, Weighted Average Remaining Life (Year)   8 years 10 months 9 days  
Outstanding, Aggregate Intrinsic Value   $ 23,040,551 $ 23,100
Exercisable, Aggregate Intrinsic Value   $ 6,876,323